Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Institute of Cancer Research, United Kingdom
UNC Lineberger Comprehensive Cancer Center
Blueprint Medicines Corporation
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Deciphera Pharmaceuticals, LLC
pharmaand GmbH
Cancer Research UK, Glasgow
University of Manchester
GOG Foundation
Australia New Zealand Gynaecological Oncology Group
Valerio Therapeutics
M.D. Anderson Cancer Center